← Back to guidelines
Cardiology7 papers

Degeneration of acoustic nerve

Last edited: 4/23/2026

Overview

Degeneration of the acoustic nerve, distinct from glaucomatous changes, refers to cavernous or atrophic alterations in the nerve often observed in elderly individuals, potentially linked to generalized arteriosclerosis and structural ocular features like large optic cups 1.

Diagnosis

  • Clinical history focusing on age, cardiovascular risk factors, and family history of cardiovascular disease 1.
  • Histopathological examination post-enucleation or biopsy revealing cavernous degeneration of the optic nerve 1.
  • Exclusion of glaucomatous changes through clinical examination and imaging 1.
  • Management

  • No specific pharmacological treatments mentioned for acoustic nerve degeneration 1.
  • Management primarily supportive, focusing on underlying conditions such as cardiovascular disease 1.
  • Special Populations

  • Elderly: Higher risk due to associated aging changes and arteriosclerosis 1.
  • Comorbidities: Presence of cardiovascular disease and arteriosclerotic changes may correlate with increased risk 1.
  • Key Recommendations

  • Consider cavernous degeneration of the optic nerve in elderly patients with a strong family history of cardiovascular disease and large optic cups 1 (Evidence: Expert opinion).
  • Exclude glaucomatous etiology through comprehensive clinical evaluation and imaging techniques 1 (Evidence: Expert opinion).
  • Address and manage associated systemic conditions, particularly cardiovascular disease, as part of overall care 1 (Evidence: Expert opinion).
  • References

    1 Brownstein S, Font RL, Zimmerman LE, Murphy SB. Nonglaucomatous cavernous degeneration of the optic nerve. Report of two cases. Archives of ophthalmology (Chicago, Ill. : 1960) 1980. link

    Original source

    1. [1]
      Nonglaucomatous cavernous degeneration of the optic nerve. Report of two cases.Brownstein S, Font RL, Zimmerman LE, Murphy SB Archives of ophthalmology (Chicago, Ill. : 1960) (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG